Veeva's AI Ambitions Face Off Against Eli Lilly's Biopharma Dominance The intersection of technology and biopharmaceuticals is on full display in the recent partnership between Veeva Systems Inc.
(NYSE:VEEV) and Eli Lilly and Company (NYSE:LLY). Veeva, a leading enterprise software provider, will deploy its AI driven commercial framework, Vault CRM, globally for Lilly's pharmaceutical applications.
This partnership brings together two industry leaders with different strengths and weaknesses.